The Future Of Private Biotech Investment: A Q&A With Jonathan Leff

Long-time Warburg Pincus investor Jonathan Leff is making a move to Deerfield Management. He tells “The Pink Sheet” about his plans and contemplates what’s next for investment in private biotechs.

More from Archive

More from Pink Sheet